Brain 17 Vienna

Conclusions

• Systemic therapies can improve outcome in brain tumor patients • Blood brain barrier can be a limiting factor • Insufficient understanding of tumor biology as one limiting factor • Emerging targeted agents with putative activity in brain tumors • Predictive factors may help to tailor systemic therapies • Need for more research